Suppr超能文献

胆管肿瘤标志物。

Markers of bile duct tumors.

机构信息

Giulia Malaguarnera, Clorinda Mazzarino, Department of Biomedical Science, University of Catania, via Androne 83, 95124 Catania, Italy.

出版信息

World J Gastrointest Oncol. 2011 Apr 15;3(4):49-59. doi: 10.4251/wjgo.v3.i4.49.

Abstract

Biliary tract carcinomas are relatively rare, representing less than 1% of cancers. However, their incidence has increased in Japan and in industrialized countries like the USA. Biliary tract tumors have a poor prognosis and a high mortality rate because they are usually detected late in the course of the disease; therapeutic treatment options are often limited and of minimal utility. Recent studies have shown the importance of serum and molecular markers in the diagnosis and follow up of biliary tract tumors. This review aims to introduce the main features of the most important serum and molecular markers of biliary tree tumors. Some considerable tumor markers are cancer antigen 125, carbohydrate antigen 19-9, carcinoembryonic antigen, chromogranin A, mucin 1, mucin 5, alpha-fetoprotein, claudins and cytokeratins.

摘要

胆道癌相对少见,占癌症的比例不到 1%。然而,在日本和美国等工业化国家,其发病率有所增加。胆道肿瘤预后不良,死亡率高,因为它们通常在疾病过程的晚期才被发现;治疗选择往往有限,效果甚微。最近的研究表明,血清和分子标志物在胆道肿瘤的诊断和随访中具有重要意义。本综述旨在介绍胆道肿瘤最重要的血清和分子标志物的主要特征。一些重要的肿瘤标志物有癌抗原 125、糖类抗原 19-9、癌胚抗原、嗜铬粒蛋白 A、黏蛋白 1、黏蛋白 5、甲胎蛋白、claudins 和细胞角蛋白。

相似文献

1
Markers of bile duct tumors.
World J Gastrointest Oncol. 2011 Apr 15;3(4):49-59. doi: 10.4251/wjgo.v3.i4.49.
2
Neuroendocrine tumor of the common bile duct: case report.
G Chir. 2016 Nov-Dec;37(6):275-280. doi: 10.11138/gchir/2016.37.6.275.
8
Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Dig Dis Sci. 2015 May;60(5):1273-83. doi: 10.1007/s10620-014-3472-0. Epub 2014 Dec 9.
10
Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
Am J Surg Pathol. 2002 Aug;26(8):989-97. doi: 10.1097/00000478-200208000-00003.

引用本文的文献

1
Quantitative MRCP metrics as imaging biomarkers to differentiate benign from malignant bile duct obstructions.
Front Oncol. 2025 May 6;15:1576163. doi: 10.3389/fonc.2025.1576163. eCollection 2025.
2
Establishment and characterization of a novel human gallbladder cancer cell line, GBC-X1.
Sci Rep. 2024 Sep 13;14(1):21439. doi: 10.1038/s41598-024-72830-0.
3
Current Status of Protein Biomarkers in Urolithiasis-A Review of the Recent Literature.
J Clin Med. 2023 Nov 16;12(22):7135. doi: 10.3390/jcm12227135.
4
Homologous Recombination Repair in Biliary Tract Cancers: A Prime Target for PARP Inhibition?
Cancers (Basel). 2022 May 23;14(10):2561. doi: 10.3390/cancers14102561.
8
Investigation of HNF-1B as a diagnostic biomarker for pancreatic ductal adenocarcinoma.
Biomark Res. 2018 Jul 27;6:25. doi: 10.1186/s40364-018-0139-6. eCollection 2018.
9
Dynamics of liver enzymes in rabbits experimentally infected with Fasciola sp. (Intermediate form from Japan).
J Vet Med Sci. 2018 Jan 1;80(1):36-40. doi: 10.1292/jvms.17-0315. Epub 2017 Nov 9.
10
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.
Tumour Biol. 2016 Mar;37(3):4041-52. doi: 10.1007/s13277-015-4215-3. Epub 2015 Oct 20.

本文引用的文献

1
Serum markers of hepatocellular carcinoma.
Dig Dis Sci. 2010 Oct;55(10):2744-55. doi: 10.1007/s10620-010-1184-7. Epub 2010 Mar 26.
2
Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma.
World J Gastroenterol. 2009 Nov 14;15(42):5279-86. doi: 10.3748/wjg.15.5279.
3
Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
J Gastroenterol Hepatol. 2010 Jan;25(1):129-37. doi: 10.1111/j.1440-1746.2009.05988.x. Epub 2009 Sep 27.
4
Chromogranin A (CgA) serum level as a marker of progression in hepatocellular carcinoma (HCC) of elderly patients.
Arch Gerontol Geriatr. 2010 Jul-Aug;51(1):81-5. doi: 10.1016/j.archger.2009.08.004. Epub 2009 Sep 19.
5
The role of immunity in elderly cancer.
Crit Rev Oncol Hematol. 2010 Apr;74(1):40-60. doi: 10.1016/j.critrevonc.2009.06.002. Epub 2009 Jul 4.
7
Serum and bile biomarkers for cholangiocarcinoma.
Curr Opin Gastroenterol. 2009 May;25(3):279-84. doi: 10.1097/mog.0b013e328325a894.
9
Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma.
Hepatogastroenterology. 2008 Nov-Dec;55(88):2000-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验